These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25158302)

  • 21. Clinical value of drugs targeting inflammation for the management of coronary artery disease.
    Duchatelle V; Kritikou EA; Tardif JC
    Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor modulation in cardiovascular disease: a target for intervention?
    Földes G; von Haehling S; Anker SD
    Expert Opin Investig Drugs; 2006 Aug; 15(8):857-71. PubMed ID: 16859390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of genetic polymorphisms of TLR2 and TLR4 in Turkish patients with coronary artery disease.
    Guven M; Ismailoglu Z; Batar B; Unal S; Onaran I; Karadag B; Ongen Z
    Gene; 2015 Mar; 558(1):99-102. PubMed ID: 25542811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis.
    Wu XD; Zeng K; Liu WL; Gao YG; Gong CS; Zhang CX; Chen YQ
    Int J Sports Med; 2014 Apr; 35(4):344-50. PubMed ID: 24022569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
    Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
    Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activation of mTOR is required for monocyte pro-inflammatory response in patients with coronary artery disease.
    Gao S; Liu W; Zhuo X; Wang L; Wang G; Sun T; Zhao Z; Liu J; Tian Y; Zhou J; Yuan Z; Wu Y
    Clin Sci (Lond); 2015 Apr; 128(8):517-26. PubMed ID: 25428582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility.
    Avlas O; Fallach R; Shainberg A; Porat E; Hochhauser E
    Antioxid Redox Signal; 2011 Oct; 15(7):1895-909. PubMed ID: 21126202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory strategies in coronary atherosclerosis.
    Burton PB; Daniel TO
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1725-8. PubMed ID: 12528306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.
    Erickson B; Sperber K; Frishman WH
    Cardiol Rev; 2008; 16(6):273-9. PubMed ID: 18923230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
    Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
    Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of TLR4 signaling pathway: molecular treatment strategy of periodontitis-associated atherosclerosis.
    Huang B; Chen H; Fan M
    Med Hypotheses; 2008; 70(3):614-7. PubMed ID: 17681703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U; Libby P
    Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
    Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z
    J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway.
    Chen CY; Kao CL; Liu CM
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogen-associated molecular patterns initiate inflammation and perturb the endocrine function of bovine granulosa cells from ovarian dominant follicles via TLR2 and TLR4 pathways.
    Price JC; Bromfield JJ; Sheldon IM
    Endocrinology; 2013 Sep; 154(9):3377-86. PubMed ID: 23825132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in studies on TLR4 signaling pathway and major depressive disorder].
    Wang L; Chen J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):725-729. PubMed ID: 28690233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptors in innate immunity: role of bacterial endotoxin and toll-like receptor 4 in endometrium and endometriosis.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
    Gynecol Obstet Invest; 2009; 68(1):40-52. PubMed ID: 19365133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.